63 related articles for article (PubMed ID: 19220364)
1. Prediction of chronic allograft damage index of renal allografts using serum level of plasminogen activator inhibitor-1.
Chang HR; Yang SF; Lian JD; Lin CC; Wen MC; Chen YT; Jan YJ; Hsieh YS
Clin Transplant; 2009; 23(2):206-12. PubMed ID: 19220364
[TBL] [Abstract][Full Text] [Related]
2. Chronic allograft nephropathy: expression and localization of PAI-1 and PPAR-gamma.
Revelo MP; Federspiel C; Helderman H; Fogo AB
Nephrol Dial Transplant; 2005 Dec; 20(12):2812-9. PubMed ID: 16221712
[TBL] [Abstract][Full Text] [Related]
3. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M
Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
[TBL] [Abstract][Full Text] [Related]
4. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta 1 in renal allograft recipients.
Coupes BM; Newstead CG; Short CD; Brenchley PE
Transplantation; 1994 Jun; 57(12):1727-31. PubMed ID: 8016876
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts.
Frank K; Zeier M; Gross ML; Waldherr R; Ritz E; Amann K
Nephrol Dial Transplant; 2006 May; 21(5):1365-72. PubMed ID: 16449275
[TBL] [Abstract][Full Text] [Related]
7. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
[TBL] [Abstract][Full Text] [Related]
8. Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathy.
Falger JC; Mueller T; Arbeiter K; Boehm M; Regele H; Balzar E; Aufricht C
Pediatr Transplant; 2006 Jun; 10(4):474-8. PubMed ID: 16712606
[TBL] [Abstract][Full Text] [Related]
9. C4d as a significant predictor for humoral rejection in renal allografts.
Jianghua C; Wenqing X; Huiping W; Juan J; Jianyong W; Qiang H
Clin Transplant; 2005 Dec; 19(6):785-91. PubMed ID: 16313326
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the accuracy of functional biomarkers for detecting histological changes in chronic allograft nephropathy.
Yilmaz S; Isik I; Afrouzian M; Monroy M; Sar A; Benediktsson H; McLaughlin K
Transpl Int; 2007 Jul; 20(7):608-15. PubMed ID: 17521383
[TBL] [Abstract][Full Text] [Related]
11. Can histopathological findings in early renal allograft biopsies identify patients at risk for chronic vascular rejection?
Dimény E; Wahlberg J; Larsson E; Fellström B
Clin Transplant; 1995 Apr; 9(2):79-84. PubMed ID: 7599406
[TBL] [Abstract][Full Text] [Related]
12. The effect of chronic allograft rejection on plasma regulators of fibrinolysis.
Perkowska A; Elhasade A; Durlik M; Placha G; Gałazka Z; Lao M; Gaciong Z
Ann Transplant; 2002; 7(1):44-51. PubMed ID: 12221903
[TBL] [Abstract][Full Text] [Related]
13. Conversion of ciclosporin A to tacrolimus in kidney transplant recipients with chronic allograft nephropathy.
Tang SC; Chan KW; Tang CS; Lam MF; Leung CY; Tse KC; Li CS; Ho YW; Tong MK; Lai KN; Chan TM;
Nephrol Dial Transplant; 2006 Nov; 21(11):3243-51. PubMed ID: 16877482
[TBL] [Abstract][Full Text] [Related]
14. Timing and value of protocol biopsies in well-matched kidney transplant recipients--a clinical and histopathologic analysis.
Helanterä I; Ortiz F; Helin H; Räisänen-Sokolowski A; Honkanen E; Koskinen P
Transpl Int; 2007 Nov; 20(11):982-90. PubMed ID: 17711407
[TBL] [Abstract][Full Text] [Related]
15. Acute renal allograft rejection is associated with increased levels of vascular endothelial growth factor in the urine.
Peng W; Chen J; Jiang Y; Shou Z; Chen Y; Wang H
Nephrology (Carlton); 2008 Feb; 13(1):73-9. PubMed ID: 18199108
[TBL] [Abstract][Full Text] [Related]
16. PAI-1 donor polymorphism influences long-term kidney graft survival.
Rérolle JP; Munteanu E; Drouet M; Szelag JC; Champtiaux B; Yagoubi F; Preux PM; Aldigier JC; Le Meur Y
Nephrol Dial Transplant; 2008 Oct; 23(10):3325-32. PubMed ID: 18463321
[TBL] [Abstract][Full Text] [Related]
17. Increased urinary excretion of monocyte chemoattractant protein-1 during acute renal allograft rejection.
Prodjosudjadi W; Daha MR; Gerritsma JS; Florijn KW; Barendregt JN; Bruijn JA; van der Woude FJ; van Es LA
Nephrol Dial Transplant; 1996 Jun; 11(6):1096-103. PubMed ID: 8671975
[TBL] [Abstract][Full Text] [Related]
18. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
Sundberg AK; Rohr MS; Hartmann EL; Adams PL; Stratta RJ
Clin Transplant; 2004; 18 Suppl 12():61-6. PubMed ID: 15217410
[TBL] [Abstract][Full Text] [Related]
19. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.
Castroagudín JF; Molina E; Romero R; Otero E; Tomé S; Varo E
Liver Transpl; 2009 Dec; 15(12):1792-7. PubMed ID: 19938140
[TBL] [Abstract][Full Text] [Related]
20. Resistive index and chronic allograft nephropathy evaluated in protocol biopsies as predictors of graft outcome.
Vallejos A; Alperovich G; Moreso F; Cañas C; de Lama ME; Gomà M; Fulladosa X; Carrera M; Hueso M; Grinyó JM; Serón D
Nephrol Dial Transplant; 2005 Nov; 20(11):2511-6. PubMed ID: 16077142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]